(Q40943329)

25 September 2017

1 reference

title

Cognition enhancers in age-related cognitive decline (English)

1 reference

25 September 2017

W J Riedel

1

1 reference

PubMed ID

8920174

25 September 2017

J Jolles

series ordinal

2

1 reference

25 September 2017

1 April 1996

1 reference

25 September 2017

1 reference

25 September 2017

8

1 reference

25 September 2017

4

1 reference

25 September 2017

245-274

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-199608040-00003

25 September 2017

0 references

cites work

Facts and fiction about memory aging: a quantitative integration of research findings

1 reference

12 December 2020

A double-blind, placebo controlled study of Ginkgo biloba extract ('tanakan') in elderly outpatients with mild to moderate memory impairment

1 reference

12 December 2020

Cognition enhancers: from animals to man. Proceedings of the Second International I.T.E.M.-Labo Symposium on Strategies in Psychopharmacology. Paris, October 12-14, 1988

1 reference

12 December 2020

Beta-carbolines as tools in memory research: animal data and speculations

1 reference

12 December 2020

The separate and combined effects of scopolamine and nicotine on human information processing

1 reference

12 December 2020

EEG profile of three different extractions of Ginkgo biloba.

1 reference

12 December 2020

Differential effects of scopolamine and amphetamine on microcomputer-based performance tests

1 reference

12 December 2020

The hypoxia model in human psychopharmacology: neurophysiological and psychometric studies with aniracetam i.v.

1 reference

12 December 2020

The families of cognition enhancers

1 reference

12 December 2020

Thyrotropin-releasing hormone selectively reverses lorazepam-induced sedation but not slowing of saccadic eye movements

1 reference

12 December 2020

Memory disorders: novel treatments, clinical perspective

1 reference

12 December 2020

Blood glucose and human memory.

1 reference

12 December 2020

Information processing in depression and anxiety.

1 reference

12 December 2020

Effects of NMDA Modulation in Scopolamine Dementiaa

1 reference

12 December 2020

Therapy with l-deprenyl (selegiline) and relation to abuse liability.

1 reference

12 December 2020

The influence of aging and attentional demands on recovery from postural instability

1 reference

12 December 2020

EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trials

1 reference

12 December 2020

Antagonistic effects of caffeine and alcohol on mental performance parameters.

1 reference

12 December 2020

Therapy with central active catechol-O-methyltransferase (COMT)-inhibitors: is addition of monoamine oxidase (MAO)-inhibitors necessary to slow progress of neurodegenerative disorders?

1 reference

12 December 2020

The use of a scopolamine model to study the potential nootropic effects of aniracetam and piracetam in healthy volunteers.

1 reference

12 December 2020

Early clinical testing of cognition enhancers: prediction of efficacy

1 reference

12 December 2020

Double-blind placebo-controlled, neuropsychological and neurophysiological investigations with oxiracetam (CGP 21690E) in memory-impaired patients with epilepsy

1 reference

12 December 2020

The effects of pre-treatment with enalapril maleate on scopolamine-induced cognitive deficits in healthy volunteers.

1 reference

12 December 2020

The effects of age on the response to caffeine

1 reference

12 December 2020

Aniracetam tested in chronic psychosyndrome after long-term exposure to organic solvents. A randomized, double-blind, placebo-controlled cross-over study with neuropsychological tests

1 reference

12 December 2020

Early human trials in the assessment of cognition activators

1 reference

12 December 2020

Learning and retrieval rate of words presented auditorily and visually.

1 reference

12 December 2020

1 reference

12 December 2020

Serotonin: neurotransmitter "a la mode". Report on the Third International I.T.E.M.-LABO symposium on strategies in psychopharmacology: serotonin: animal models and clinical targets

1 reference

12 December 2020

Reasons for prescribing cognition enhancers in primary care. Results of a representative survey in Lower Saxony, Germany.

1 reference

12 December 2020

TRH attenuates scopolamine-induced memory impairment in humans

1 reference

12 December 2020

Influence of caffeine on information processing stages in well rested and fatigued subjects.

1 reference

12 December 2020

Effects of estrogen on memory function in surgically menopausal women

1 reference

12 December 2020

Late clinical testing of cognition enhancers: demonstration of efficacy

1 reference

12 December 2020

Effects of vasopressin on event-related potential indicators of cognitive stimulus processing in young and old humans

1 reference

12 December 2020

Phosphatidylserine: Quantitative EEG Effects in Healthy Volunteers

1 reference

12 December 2020

Psychopharmacological effects of pyritinol in normal volunteers

1 reference

12 December 2020

Study of the potential reversal of triazolam memory and cognitive deficits by RU 41 656 in healthy subjects

1 reference

12 December 2020

Cholinergic blockade and human information processing: are we asking the right questions?

1 reference

12 December 2020

Effects of phosphatidylserine in age-associated memory impairment.

1 reference

12 December 2020

Effect of phosphatidylcholine on explicit memory

1 reference

12 December 2020

An hypothesis on the role of glucose in the mechanism of action of cognitive enhancers

1 reference

12 December 2020

Epidemiologic study on the effectiveness and safety of dihydroergocristine in impaired memory and behavioral functions in aged humans

1 reference

12 December 2020

L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibition

1 reference

12 December 2020

Differentiating the sedative, psychomotor and amnesic effects of benzodiazepines: a study with midazolam and the benzodiazepine antagonist, flumazenil

1 reference

12 December 2020

Does caffeine intake enhance absolute levels of cognitive performance?

1 reference

12 December 2020

Ginkgo biloba for cerebral insufficiency

1 reference

12 December 2020

Caffeine attenuates scopolamine-induced memory impairment in humans.

1 reference

12 December 2020

Double-blind, placebo-controlled, pharmacokinetic and -dynamic studies with 2 new formulations of piracetam (infusion and sirup) under hypoxia in man

1 reference

12 December 2020

Distinguishing between attentional and amnestic effects in information processing: the separate and combined effects of scopolamine and nicotine on verbal free recall.

1 reference

12 December 2020

Models of hypoxia and cerebral ischemia

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of age-associated memory impairment with guanfacine

1 reference

12 December 2020

Rigorous health screening reduces age effect on memory scanning task.

1 reference

12 December 2020

Effects of altitude on mood, behaviour and cognitive functioning. A review

1 reference

12 December 2020

Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors

1 reference

12 December 2020

A comparison of the CNS effects of enprofylline and theophylline in healthy subjects assessed by performance testing and subjective measures

1 reference

12 December 2020

Cholinergic function in the aged brain: implications for treatment of memory impairments associated with aging.

1 reference

12 December 2020

Piracetam and other structurally related nootropics

1 reference

12 December 2020

The effects of low doses of caffeine on human performance and mood.

1 reference

12 December 2020

Towards a model of stress and human performance

1 reference

12 December 2020

Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I.

1 reference

12 December 2020

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

12 December 2020

Niacin and vitamin B6 in mental functioning: A review of controlled trials in humans

1 reference

12 December 2020

Effects of acute doses of oxiracetam in the scopolamine model of human amnesia

1 reference

12 December 2020

The amnesic action of benzodiazepines in man.

1 reference

12 December 2020

Age associated memory impairment

1 reference

12 December 2020

Does nicotine improve cognitive function?

1 reference

12 December 2020

Topographic brain mapping of EEG after acute application of ergotalkaloids in the elderly.

1 reference

12 December 2020

Cholinesterase Inhibition in the Scopolamine Model of Dementia

1 reference

12 December 2020

Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro 15-1788 and physostigmine.

1 reference

12 December 2020

1 reference

12 December 2020

Psychopharmacology and successful cerebral aging

1 reference

12 December 2020

Effects of the cholinomimetic SDZ ENS-163 on scopolamine-induced cognitive impairment in humans

1 reference

12 December 2020

Influence of desglycinamide-(arg8) vasopressin on memory in healthy subjects.

1 reference

12 December 2020

The "nootropic" approach to the pharmacology of the integrative activity of the brain

1 reference

12 December 2020

Caffeine and theophylline as adenosine receptor antagonists in humans

1 reference

12 December 2020

Topographic brain mapping of EEG in neuropsychopharmacology--Part II. Clinical applications (pharmaco EEG imaging).

1 reference

12 December 2020

The differential effects of flumazenil on the psychomotor and amnesic actions of midazolam

1 reference

12 December 2020

On the cognitive penetrability of posture control

1 reference

12 December 2020

Scopolamine-induced amnesia in humans: lack of effects of the benzodiazepine receptor antagonist β-carboline ZK 93426.

1 reference

12 December 2020

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

12 December 2020

Development of tolerance after repeated administration of a selective muscarinic M1 antagonist biperiden in healthy human volunteers.

1 reference

12 December 2020

A computerized everyday memory battery for assessing treatment effects.

1 reference

12 December 2020

In search of the mechanism of action of the nootropics: new insights and potential clinical implications

1 reference

12 December 2020

A comparison of the central nervous system effects of caffeine and theophylline in elderly subjects

1 reference

12 December 2020

Separate and combined effects of the social drugs on psychomotor performance

1 reference

12 December 2020

Cognitive impairment in elderly people. Predisposing factors and implications for experimental drug studies.

1 reference

12 December 2020

Topographic mapping of cognitive event-related potentials in a double-blind, placebo-controlled study with the hemoderivative Actovegin in age-associated memory impairment

1 reference

12 December 2020

Priming and cued recall in elderly, alcohol intoxicated and sleep deprived subjects: a case of functionally similar memory deficits

1 reference

12 December 2020

In vivo probe of central cholinergic systems

1 reference

12 December 2020

First clinical impressions with an ACTH analog (HOE 427) in the treatment of Alzheimer's disease

1 reference

12 December 2020

Human memory and the cholinergic system. A relationship to aging?

1 reference

12 December 2020

Almitrine-raubasine and cognitive impairment in the elderly: results of a 6-month controlled multicenter study.

1 reference

12 December 2020

The effect of the benzodiazepine antagonist, flumazenil, on psychometric performance in acute ethanol intoxication in man.

1 reference

12 December 2020

Psychomotor, physiological and cognitive effects of scopolamine and ephedrine in healthy man.

1 reference

12 December 2020

Effects of scopolamine and dextroamphetamine on human performance.

1 reference

12 December 2020

Indomethacin and cognitive function in healthy elderly volunteers

1 reference

12 December 2020

Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons

1 reference

12 December 2020

The interactions of midazolam and flumazenil on human memory and cognition.

1 reference

12 December 2020

Vitamin B-6 supplementation in elderly men: effects on mood, memory, performance and mental effort

1 reference

12 December 2020

Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model

1 reference

12 December 2020

Effects of oxazepam and an extract of kava roots (Piper methysticum) on event-related potentials in a word recognition task.

1 reference

12 December 2020

Glycine prodrug facilitates memory retrieval in humans

1 reference

12 December 2020

Co-dergocrine mesylate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in age-related cognitive decline

1 reference

12 December 2020

Cholinergic 'blockade' as a model for cholinergic depletion. A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome

1 reference

12 December 2020

Should aging-associated cognitive decline be included in DSM-IV?

1 reference

12 December 2020

Memory-scanning: mental processes revealed by reaction-time experiments

1 reference

12 December 2020

The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type

1 reference

12 December 2020

Vitamin-mineral supplements and intelligence

1 reference

12 December 2020

Potential of moclobemide to improve cerebral insufficiency identified using a scopolamine model of aging and dementia

1 reference

12 December 2020

Breakfast, blood glucose and memory

1 reference

12 December 2020

An update on research with coffee/caffeine (1989-1990)

1 reference

12 December 2020

Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders

1 reference

12 December 2020

Pramiracetam effects on scopolamine-induced amnesia in healthy volunteers.

1 reference

12 December 2020

Single doses of piracetam affect 42-channel event-related potential microstate maps in a cognitive paradigm.

1 reference

12 December 2020

Glutamatergic treatment strategies for age-related memory disorders

1 reference

12 December 2020

The cholinergic neurotransmitter system in human memory and dementia: a review

1 reference

12 December 2020

Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition.

1 reference

12 December 2020

The hyperventilation-induced ischaemia model in human neuropharmacology: neurophysiological and psychometric studies of aniracetam and 3-OH aniracetam

1 reference

12 December 2020

Acute nicotinic blockade produces cognitive impairment in normal humans.

1 reference

12 December 2020

Relation between nicotine intake and Alzheimer's disease

1 reference

12 December 2020

Treatment strategies for senile dementia: antagonist beta-carbolines

1 reference

12 December 2020

Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease

1 reference

12 December 2020

Piracetam in Elderly Motorists

1 reference

12 December 2020

Senescent forgetfulness: benign and malignant

1 reference

12 December 2020

Milacemide and Other Drugs Active at Glutamate NMDA Receptors as Potential Treatment for Dementia

1 reference

12 December 2020

Drug therapy and memory training programs: a double-blind randomized trial of general practice patients with age-associated memory impairment.

1 reference

12 December 2020

The effects of alcohol and other drugs on psychomotor performance and cognitive function.

1 reference

12 December 2020

The effects of ACE inhibitors on cognitive function.

1 reference

12 December 2020

Effects of scopolamine and nicotine on human rapid information processing performance

1 reference

12 December 2020

Age-associated memory impairment: a role for catecholamines

1 reference

12 December 2020

Age, alcohol, and simulated altitude: effects on performance and breathalyzer scores.

1 reference

12 December 2020

Sleep deprivation and impaired cognition. Possible role of brain catecholamines

1 reference

12 December 2020

On brain protection of co-dergocrine mesylate (Hydergine) against hypoxic hypoxidosis of different severity: double-blind placebo-controlled quantitative EEG and psychometric studies.

1 reference

12 December 2020

The impact of long-term vitamin supplementation on cognitive functioning.

1 reference

12 December 2020

Dissociation of benzodiazepine-induced amnesia from sedation by flumazenil pretreatment.

1 reference

12 December 2020

Caffeine moderately antagonizes the effects of triazolam and zopiclone on the psychomotor performance of healthy subjects

1 reference

12 December 2020

Influence of caffeine on selective attention in well-rested and fatigued subjects.

1 reference

12 December 2020

Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease.

1 reference

12 December 2020

Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects

1 reference

12 December 2020

Effect of a single dose of des-glycinamide-[Arg8]vasopressin or oxytocin on cognitive processes in young healthy subjects

1 reference

12 December 2020

The cholinergic hypothesis: a historical overview, current perspective, and future directions

1 reference

12 December 2020

Treatment of the alcoholic organic brain syndrome: double-blind, placebo-controlled clinical, psychometric and electroencephalographic mapping studies with modafinil.

1 reference

12 December 2020

Stroop interference: aging effects assessed with the Stroop Color-Word Test.

1 reference

12 December 2020

RU 41 656 does not reverse the scopolamine-induced cognitive deficit in healthy volunteers

1 reference

12 December 2020

Amphetamine enhances human-memory consolidation

1 reference

12 December 2020

The effects of nicotinic acid and xanthinol nicotinate on human memory in different categories of age. A double blind study.

1 reference

12 December 2020

Biochemical strategies in the search for cognition enhancers

1 reference

12 December 2020

Age-associated memory impairment diagnoses: problems of reliability and concerns for terminology.

1 reference

12 December 2020

Serotonin, memory, and the aging brain

1 reference

12 December 2020

BMS-181168 for protection of the human brain against hypoxia: double-blind, placebo-controlled EEG mapping studies.

1 reference

12 December 2020

Evidence for a central cholinergic effect of high-dose thiamine.

1 reference

12 December 2020

Effects of nicotine gum on psychomotor performance in smokers and non-smokers.

1 reference

12 December 2020

Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part II.

1 reference

12 December 2020

Chronic administration of sulbutiamine improves long term memory formation in mice: possible cholinergic mediation

1 reference

12 December 2020

Brain aging: a risk factor of neurodegenerative disorders and a target for therapeutic intervention.

1 reference

12 December 2020

Does "benign senescent forgetfulness" exist?

1 reference

12 December 2020

A low dose of subcutaneous nicotine improves information processing in non-smokers

1 reference

12 December 2020

A controlled trial with vasopressin analogue (DGAVP) on cognitive recovery immediately after head trauma.

1 reference

12 December 2020

10.2165/00002512-199608040-00003

Identifiers

DOI

1 reference

PubMed ID

8920174

Dimensions Publication ID

25 September 2017

0 references

1 reference

PubMed ID

8920174